Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas

Molecular Carcinogenesis

Volumn 21, Issue 2, 1998, Pages 81-86

  Ruggeri, Bruce A ^a   Huang, Lingyi ^a   Wood, Moira ^a   Cheng, Jin Quan ^b   Testa, Joseph R ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

AKT2 oncogene; Gene amplification; Immunohistochemistry; Pancreatic cancer

Indexed keywords

PHOSPHATIDYLINOSITOL; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENICITY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; ONCOGENE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL;

CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS; ONCOGENES; PANCREAS; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR CELLS, CULTURED;

EID: 0031936947     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R     Document Type: Article

References (25)

1. Warshaw AL, Fernandez-Del Castillo C. Pancreatic carcinoma. N Engl J Med 326:455-465, 1992.
2. Murr MM, Sarr MG, Oishi AJ, van Heerden JA. Pancreatic can cer. CA Cancer J Clin 44:304-318, 1994.
3. Hahn SA, Kern SE, Molecular genetics of exocrine pancreatic neoplasms, Surg Clin North Am 75:857-869, 1995.
4. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-RAS genes. Cell 53:549-554, 1988.
5. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102:230-236; 1992.
6. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53:953-956, 1993.
7. Hruban RH, van Mansfeld ADM, Offerhaus GJA. K-RAS oncogene activation in adenocarcinoma of the human pancreas-A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 43:545-554, 1993.
8. Brentnall TA, Chen R, Lee JG, et al. Microsatellite instability and K-RAS mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264-4267, 1995.
9. Cheng JQ, Rugged B, Klein WM, et al. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636-3641, 1996.
10. Miwa W, Yasuda J, Murakami Y, et al. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem Biophys Res Commun 225:968-974, 1996.
11. Cheng JQ, Godwin AK, Bellacosa A, et al. AKT2, a putative oncogene encoding a member of a subfamily of protein serine/ threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271, 1992.
12. Bellacosa A, deFeo D, Godwin AK, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280-285, 1995.
13. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, Akt encoding a serine-threonine kinase containing an SH2like region. Science 254:274-277, 1991.
14. Mayer BJ, Ren R, Clark KL, Baltimore D. A putative modular domain present in diverse signaling proteins. Cell 73:629-630, 1993.
15. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M, The PH domain: A common piece in the structural patchwork of signaling proteins. Trends Biochem Sci 18:343-348, 1993.
16. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736, 1995.
17. Burgering BMT, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602, 1995.
18. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789, 1995.
19. Leung HY, Gullick WJ, Lemoine NR. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 59:667-675, 1994.
20. Ebert M, Yokoyama M, Friess H, Kobrin MS, Buchler MW, Korc M. Induction of platelet-derived growth factor A and B chains and over expression of their receptors in human pancreatic cancer. Int J Cancer 62:529-535, 1995.
21. Lemoine NR, Hughes CM, Barton CM, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166:7-12, 1992.
22. Friess H, Berberat P, Schilling M, Kunz J, Korc M, Buchler MW. Pancreatic cancer: The potential clinical relevance of alterations in growth factors and their receptors. J Mol Med 74:35-42, 1996.
23. Cheng JQ, Altornare DA, Klein MA, et al. Transforming activity and mitosis-related expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14:2793-2801, 1997.
24. Ruggeri BA, Huang L, Berger D, et al. Molecular pathology of primary and metastatic ductal pancreatic lesions: Analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Cancer 79:700-716, 1996.
25. Ahmed NN, Franke TF, Bellacosa A, et al. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 8:1957-1963, 1993.